Acelrx Pharma (ACRX) Starts Final Trial To Treat Post-Operative Pain
AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) said it has initiated third phase 3 clinical trial of its sublingual patient-controlled analgesia (PCA) system to treat post-operative pain. [More...]
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here